Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors

The inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) by chemical inhibitors, such as rapamycin, has demonstrated anti-cancer activity in preclinical and clinical trials. Their efficacy is, however, limited and tumors eventually relapse through resistance formation. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Faes, Seraina, Planche, Anne, Uldry, Emilie, Santoro, Tania, Pythoud, Catherine, Stehle, Jean-Christophe, Horlbeck, Janine, Letovanec, Igor, Riggi, Nicolo, Datta, Dipak, Demartines, Nicolas, Dormond, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095030/
https://www.ncbi.nlm.nih.gov/pubmed/27153561
http://dx.doi.org/10.18632/oncotarget.9134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095030/
https://www.ncbi.nlm.nih.gov/pubmed/27153561
http://dx.doi.org/10.18632/oncotarget.9134

Ejemplares similares